We at ACON Laboratories, Inc. have been continuously monitoring the emergence of COVID-19 variants.
The Omicron variant (B.1.1.529) is currently the dominant variant circulating globally, accounting fornearly all sequences reported to GISAID. Omicron is made up of several sub-lineages, the most common ones are subvariant BA.1 and BA.2.
An independent evaluation conducted by the National Institutes of Health’s (NIH) RADx program has indicated that the Flowflex™ COVID-19 Antigen Home Test does detect the Omicron subvariant BA.1 and BA.2 in live clinical samples.
ACON will continue to monitor the evolution of COVID-19 variants in circulation worldwide and evaluate the performance of our assays against future variants to maintain the high level of product performance our customers have come to rely upon.
Sincerely,
Michael Lynch
Vice President, Sales and Marketing